141
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effect of Personality Traits on Sustained Remission Among Patients with Major Depression: A 12-Month Prospective Study

, ORCID Icon, , , , , , , , , & ORCID Icon show all
Pages 2771-2781 | Received 09 Aug 2022, Accepted 09 Nov 2022, Published online: 28 Nov 2022

References

  • Herrman H, Patel V, Kieling C., et al. Time for united action on depression: a Lancet–World Psychiatric Association Commission. Lancet. 2022;399:957–1022. doi:10.1016/S0140-6736(21)00897-7
  • Kraus C, Kadriu B, Lanzenberger R, Zarate CA, Kasper S. Prognosis and improved outcomes in major depression: a review. Transl Psychiatry. 2019;9(1):127. doi:10.1038/s41398-019-0460-3
  • Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299–2312. doi:10.1016/S0140-6736(18)31948-2
  • Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48:851–855. doi:10.1001/archpsyc.1991.01810330075011
  • Furukawa TA, Fujita A, Harai H, Yoshimura R, Kitamura T, Takahashi K. Definitions of recovery and outcomes of major depression: results from a 10-year follow-up. Acta Psychiatr Scand. 2008;117:35–40. doi:10.1111/j.1600-0447.2007.01119.x
  • Furukawa TA, Takeuchi H, Hiroe T, et al. Symptomatic recovery and social functioning in major depression. Acta Psychiatr Scand. 2001;103:257–261. doi:10.1034/j.1600-0447.2001.00140.x
  • Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917. doi:10.1176/ajp.2006.163.11.1905
  • Souery D, Amsterdam J, de Montigny C, et al. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol. 1999;9:83–91. doi:10.1016/s0924-977x(98)00004-2
  • Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40. doi:10.1176/appi.ajp.163.1.28
  • Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013;58:376–385. doi:10.1177/070674371305800702
  • Nakagawa A, Mitsuda D, Sado M, et al. Effectiveness of supplementary cognitive-behavioral therapy for pharmacotherapy-resistant depression: a randomized controlled trial. J Clin Psychiatry. 2017;78:1126–1135. doi:10.4088/JCP.15m10511
  • Wiles NJ, Thomas L, Turner N, et al. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial. Lancet Psychiatry. 2016;3:137–144. doi:10.1016/S2215-0366(15)00495-2
  • Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361:653–661. doi:10.1016/S0140-6736(03)12599-8
  • Glue P, Donovan MR, Kolluri S, Emir B. Meta-analysis of relapse prevention antidepressant trials in depressive disorders. Aust N Z J Psychiatry. 2010;44:697–705. doi:10.3109/00048671003705441
  • Hirschfeld RM, Schatzberg AF. Long-term management of depression. Am J Med. 1994;97:33S–38S. doi:10.1016/0002-9343(94)90361-1
  • NHS England & NHS Improvement, 2018. The Improving Access to Psychological Therapies (IAPT) pathway for people with long-term physical health conditions and medically unexplained symptoms. Available from: https://www.england.nhs.uk/publication/the-improving-access-to-psychological-therapies-iapt-pathway-for-people-with-long-term-physical-health-conditions-and-medically-unexplained-symptoms/. Accessed August 3, 2022.
  • Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49:1087–1206. doi:10.1177/0004867415617657
  • Wright CD, Tiani AG, Billingsley AL, Steinman SA, Larkin KT, McNeil DW. A framework for understanding the role of psychological processes in disease development, maintenance, and treatment: the 3P-disease model. Front Psychol. 2019;10:2498. doi:10.3389/fpsyg.2019.02498
  • Klein DN, Kotov R, Bufferd SJ. Personality and depression: explanatory models and review of the evidence. Annu Rev Clin Psychol. 2011;7:269–295. doi:10.1146/annurev-clinpsy-032210-104540
  • Morris BH, Bylsma LM, Rottenberg J. Does emotion predict the course of major depressive disorder? A review of prospective studies. Br J Clin Psychol. 2009;48:255–273. doi:10.1348/014466508X396549
  • Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry. 2002;159:359–371. doi:10.1176/appi.ajp.159.3.359
  • Duggan CF, Lee AS, Murray RM. Does personality predict long-term outcome in depression? Br J Psychiatry. 1990;157:19–24. doi:10.1192/bjp.157.1.19
  • Quilty LC, De Fruyt F, Rolland JP, Kennedy SH, Rouillon PF, Bagby RM. Dimensional personality traits and treatment outcome in patients with major depressive disorder. J Affect Disord. 2008;108:241–250. doi:10.1016/j.jad.2007.10.022
  • Robison EJ, Shankman SA, McFarland BR. Independent associations between personality traits and clinical characteristics of depression. J Nerv Ment Dis. 2009;197:476–483. doi:10.1097/NMD.0b013e3181aad5fc
  • Steffens DC, McQuoid DR, Smoski MJ, Potter GG. Clinical outcomes of older depressed patients with and without comorbid neuroticism. Int Psychogeriatr. 2013;25:1985–1990. doi:10.1017/S1041610213001324
  • Balestri M, Porcelli S, Souery D, et al. Temperament and character influence on depression treatment outcome. J Affect Disord. 2019;252:464–474. doi:10.1016/j.jad.2019.04.031
  • Mulder RT, Frampton CM, Luty SE, Joyce PR. Eighteen months of drug treatment for depression: predicting relapse and recovery. J Affect Disord. 2009;114:263–270. doi:10.1016/j.jad.2008.08.002
  • Mulder RT, Frampton CMA, Jordan J, Luty SE, McIntosh VVW, Carter JD. The five year outcome of major depression: effects of baseline variables and type of treatment. J Psychiatr Res. 2022;145:13–17. doi:10.1016/j.jpsychires.2021.11.039
  • Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. The influence of comorbid personality disorder and neuroticism on treatment outcome in first episode depression. Psychopathology. 2010;43:197–204. doi:10.1159/000304176
  • Spek V, Nyklícek I, Cuijpers P, Pop V. Predictors of outcome of group and internet-based cognitive behavior therapy. J Affect Disord. 2008;105:137–145. doi:10.1016/j.jad.2007.05.001
  • Parker G, Manicavasagar V, Crawford J, Tully L, Gladstone G. Assessing personality traits associated with depression: the utility of a tiered model. Psychol Med. 2006;36:1131–1139. doi:10.1017/S0033291706007562
  • Parker G, Malhi G, Mitchell P, et al. Progressing a spectrum model for defining non-melancholic depression. Acta Psychiatr Scand. 2005;111:139–143. doi:10.1111/j.1600-0447.2004.00474.x
  • Kudo Y, Nakagawa A, Wake T, et al. Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study. Neuropsychiatr Dis Treat. 2017;13:17–24. doi:10.2147/NDT.S123788
  • Lye MS, Tey YY, Tor YS, et al. Predictors of recurrence of major depressive disorder. PLoS One. 2020;15:e0230363. doi:10.1371/journal.pone.0230363
  • Parker G, Crawford J. Personality and self-reported treatment effectiveness in depression. Aust N Z J Psychiatry. 2009;43:518–525. doi:10.1080/00048670902873730
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: DSM-IV. American Psychiatric Association; 1994.
  • Parker G. Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatr Scand Suppl. 2007;433:21–30. doi:10.1111/j.1600-0447.2007.00959.x
  • Power MJ, Katz R, McGuffin P, Duggan CF, Lam D, Beck AT. The Dysfunctional Attitude Scale (DAS). J Res Pers. 1994;28:263–276. doi:10.1006/jrpe.1994.1019
  • Tajima M, Akiyama T, Numa H, et al. Reliability and validity of the Japanese version of the 24-item Dysfunctional Attitude Scale. Acta Neuropsychiatr. 2007;19:362–367. doi:10.1111/j.1601-5215.2007.00203.x
  • Weissman AN. The Dysfunctional Attitude Scale: A Validation Study. University of Pennsylvania; 1979.
  • First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Patient Ed. New York, NY: Biometrics Research Department, Columbia University; 2005.
  • Tabuse H, Kalali A, Azuma H, et al. The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Res. 2007;153:61–67. doi:10.1016/j.psychres.2006.07.004
  • Williams JB, Kobak KA, Bech P, et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin Psychopharmacol. 2008;23:120–129. doi:10.1097/YIC.0b013e3282f948f5
  • Beck AT, Steer RA, Brown GK. Bdi-Ii Manual. Antonio S. TX: The Psychological Corporation; 1996.
  • Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration. Mental Health Administration; 1976.
  • Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44:540–548. doi:10.1001/archpsyc.1987.01800180050009
  • Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T, Tokudome S. Cross-cultural validation of the Beck Depression Inventory – II in Japan. Psychiatry Res. 2002;110:291–299. doi:10.1016/s0165-1781(02)00106-3
  • Parker G, Manicavasagar V. Modelling and Managing the Depressive Disorders: A Clinical Guide. Cambridge: Cambridge University Press; 2005.
  • The Black Dog Institute, 2013. Temperament and Personality (T&P) Questionnaire. Available from: https://www.blackdoginstitute.org.au/education-services/health-professionals/psychological-toolkit/. Accessed August 3, 2022.
  • Kudo Y, Nakagawa A, Tamura N, et al. The reliability and validity of the Japanese version of the Temperament and Personality Questionnaire for patients with non-melancholic depression. J Affect Disord. 2016;198:237–241. doi:10.1016/j.jad.2016.03.046
  • O’Leary D, Costello F, Gormley N, Webb M. Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients. J Affect Disord. 2000;57:159–171. doi:10.1016/s0165-0327(99)00086-5
  • Kennedy N, Abbott R, Paykel ES. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med. 2003;33:827–838. doi:10.1017/s003329170300744x
  • Klein NS, Holtman GA, Bockting CLH, Heymans MW, Burger H. Development and validation of a clinical prediction tool to estimate the individual risk of depressive relapse or recurrence in individuals with recurrent depression. J Psychiatr Res. 2018;104:1–7. doi:10.1016/j.jpsychires.2018.06.006
  • Furukawa TA, Kato T, Shinagawa Y, et al. Prediction of remission in pharmacotherapy of untreated major depression: development and validation of multivariable prediction models. Psychol Med. 2019;49:2405–2413. doi:10.1017/S0033291718003331
  • Chin WY, Choi EP, Wan EY. Trajectory pathways for depressive symptoms and their associated factors in a Chinese primary care cohort by growth mixture modelling. PLoS One. 2016;11:e0147775. doi:10.1371/journal.pone.0147775
  • Farmer A, Redman K, Harris T, et al. Neuroticism, extraversion, life events and depression. The Cardiff Depression Study. Br J Psychiatry. 2002;181:118–122. doi:10.1017/s0007125000161823
  • Boschloo L, Schoevers RA, Beekman AT, Smit JH, van Hemert AM, Penninx BW. The four-year course of major depressive disorder: the role of staging and risk factor determination. Psychother Psychosom. 2014;83:279–288. doi:10.1159/000362563
  • Crawford JG, Parker GB, Malhi GS, Mitchell PB, Wilhelm K, Proudfoot J. Social inhibition and treatment‐resistant depression. Pers Ment Health. 2007;1:62–73. doi:10.1002/pmh.5